Even when fertilization is achieved, oxidative stress-induced damage may cause poor uterine lining function and luteal phase hormonal production resulting in implantation failure, poor embryo development, and miscarriage
That is the most substantial human outcome data currently available for a compound that people are sourcing and injecting based on internet research.[4,5] BPC-157 has been used in Phase II trials for ulcerative colitis and multiple sclerosis.[1,2] Comprehensive published results from those trials are not available in the medical literature
doi: 10.1016/j.bbadis.2004.08.005
However, the risk of certain side effects, like site irritation, is specific to injections, while the risk of skin sensitivity is higher with topical use
Dihexa has a completely unknown human safety profile with a plausible theoretical mechanism for serious harm (c-Met-mediated oncogenesis)